Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
---|
01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
01/02/2002 | EP1167373A1 Ferrocenyldiphosphine-ruthenium complexes and a hydrogenation process of exocyclic double bond of d-thiophene to d-thiophane |
01/02/2002 | EP1167368A1 Process for the preparation of 3,4-alkylenedioxythiophene-2,5-dicarboxylic acid derivatives |
01/02/2002 | EP1167367A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same |
01/02/2002 | EP1166785A1 Use of pyrazole derivatives for inhibiting thrombin-induced platelet aggregation |
01/02/2002 | EP1165566A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
01/02/2002 | EP1165555A2 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
01/02/2002 | EP1165545A1 Novel compounds |
01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
01/02/2002 | EP1021449B1 Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates |
01/02/2002 | EP0785938B1 Fused pyrrolocarbazoles |
01/01/2002 | US6335358 Lactacystin analogs |
12/27/2001 | WO2001098290A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
12/27/2001 | CA2414085A1 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
12/26/2001 | CN1328561A Pyrimidin-4-enamine as fungicide |
12/26/2001 | CN1328461A Method for preventing/treating damage to sensory hair cells and cochlear neurons |
12/25/2001 | US6333417 Contacting substituted biotin with sulfuric acid having concentration of 90% by weight or more in presence of aromatic hydrocarbon |
12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
12/20/2001 | WO2001095911A1 Protease inhibitors |
12/20/2001 | WO2001095857A2 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates |
12/20/2001 | WO2001064192A3 Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction |
12/20/2001 | DE10029078A1 Decarboxylation of 3,4-alkylenedioxythiophene dicarboxylic acids to 3,4-alkylenedioxythiophenes in an amine solvent to avoid the use of copper catalysts |
12/20/2001 | DE10029075A1 Two- or three-stage preparation of high-purity 3,4-alkylenedioxythiophene-2,5-dicarboxylic derivatives or acids is effected without isolation of the intermediates |
12/20/2001 | CA2412632A1 Hmg-coa reductase inhibitors and method |
12/20/2001 | CA2412353A1 Protease inhibitors |
12/19/2001 | EP1164121A1 Novel carboxylic acid derivatives and process for producing the same |
12/19/2001 | EP1163244A1 Thienopyrimidine compounds, their production and use |
12/19/2001 | EP1163240A1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
12/18/2001 | US6331640 Diaminopropionic acid derivatives |
12/13/2001 | WO2001094353A1 Thiophene derivatives useful as anticancer agents |
12/13/2001 | WO2001025241A3 Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides |
12/13/2001 | US20010051722 Aminoaryl Oxazolidinone N-oxides |
12/13/2001 | US20010051620 Tricyclic protein kinase inhibitors |
12/13/2001 | CA2411084A1 Thiophene derivatives useful as anticancer agents |
12/12/2001 | EP1162196A1 Fused-ring compounds and use thereof as drugs |
12/12/2001 | EP1161555A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |
12/12/2001 | EP0670751B1 Improved sensor membranes |
12/12/2001 | EP0646019B1 Biotin-DOTA conjugates and their use in pretargeting methods |
12/12/2001 | CN1326114A Image element containing closed compounds for taking pictures |
12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
12/11/2001 | US6329388 Thienopyridine compounds, their production and use |
12/11/2001 | US6329387 Use of thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
12/11/2001 | US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders |
12/11/2001 | US6329369 Methods of treating pain and other conditions |
12/06/2001 | WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx |
12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
12/06/2001 | CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx |
12/05/2001 | EP1159279A2 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents |
12/05/2001 | EP1158986A1 Protease inhibitors |
12/05/2001 | CN1075799C Monomers and composition which can be crosslinked and crosslinked polymers |
11/29/2001 | WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors |
11/29/2001 | WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
11/29/2001 | WO2001089521A1 Medicinal compositions containing thiophene derivatives |
11/29/2001 | WO2001089451A2 Protease inhibitors |
11/29/2001 | US20010047008 Allosteric adenosine receptor modulators |
11/29/2001 | US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
11/29/2001 | DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists |
11/29/2001 | CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
11/29/2001 | CA2406829A1 Protease inhibitors |
11/28/2001 | EP1158358A2 Imaging element containing a blocked photographically useful compound |
11/28/2001 | EP1157027A1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers |
11/28/2001 | EP1156808A2 Enhancement of return to independent living status with a growth hormone secretagogue |
11/27/2001 | US6323230 Epicuaneous route in the case of dermatological illnesses like psoriasis, atopic dermatitis and other similar affections, or when administered by oral or rectal route in the case of diseases of the epithelia of the lower intestines |
11/27/2001 | US6323217 Cardiovascular disorders |
11/27/2001 | US6323215 Treat and prevent disorders characterized by neuronal damage such as parkinson's disease, alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and bell's palsy. |
11/27/2001 | US6323214 Allosteric adenosine receptor modulators |
11/27/2001 | US6323208 Compounds to treat neurodegenerative, psychotropic drug and alcohol induced central and induced central and peripheral nervous system disorders. |
11/27/2001 | US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines |
11/22/2001 | WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
11/22/2001 | WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
11/22/2001 | WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors |
11/22/2001 | WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists |
11/22/2001 | WO2001087830A2 Substituted thioacetamides |
11/22/2001 | WO2001087038A2 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE |
11/22/2001 | WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
11/22/2001 | US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine |
11/22/2001 | US20010044445 Azole inhibitors of cytokine production |
11/22/2001 | CA2409225A1 Tricyclic pyrazole derivatives |
11/22/2001 | CA2409116A1 Substituted thioacetamides |
11/21/2001 | EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases |
11/21/2001 | EP1154997A1 Pharmaceutically active compounds and methods of use thereof |
11/21/2001 | EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
11/21/2001 | CN1323307A 1H-imidazopyridine derivatives |
11/21/2001 | CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
11/21/2001 | CN1323291A Diaminopropionic acid derivatives |
11/21/2001 | CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
11/21/2001 | CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides |
11/21/2001 | CN1074926C Antiarrhythmic benzodiazepines |
11/20/2001 | CA2046126C 2-thienylglycidic derivative, process for its preparation and its use as synthesis intermediate |
11/15/2001 | WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |
11/15/2001 | WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor |
11/15/2001 | WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes |
11/15/2001 | WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
11/15/2001 | CA2409758A1 Novel multicyclic compounds and the use thereof |
11/15/2001 | CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |
11/15/2001 | CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor |